F. Edmondson
Conseiller Juridique Général chez ZAI LAB LIMITED
Fortune : 433 991 $ au 30/04/2024
Postes actifs de F. Edmondson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ZAI LAB LIMITED | Conseiller Juridique Général | 07/08/2020 | - |
| Secrétaire Général | 27/06/2022 | - |
Historique de carrière de F. Edmondson
Anciens postes connus de F. Edmondson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/06/2014 | 01/08/2020 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Secrétaire Général | - | - |
Formation de F. Edmondson
| Washington & Lee University | Undergraduate Degree |
| Widener University School of Law | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Îles Cayman | 2 |
Opérationnelle
| Corporate Secretary | 2 |
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| BIOGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Bourse
- Insiders
- F. Edmondson
- Expérience
